Our Process
15+
Years of Experience
30+
Global Markets
200+
Regulatory Filings
50+
Pharma Clients
Our Vision
To be the preferred pharmaceutical R&D partner for companies seeking reliable, science-driven development and regulatory support across global markets.
Our Mission
To deliver end-to-end formulation, regulatory, and analytical services that help pharmaceutical companies bring safe, effective therapies to patients worldwide — on time and within budget.
Trusted by Leading Pharmaceutical Companies
Our Commitment
Five Core Values Of
Sanmour
Integrity
We conduct our business fairly, with honesty and transparency. Everything we do must stand the test of public scrutiny.
Understanding
We care, show respect, compassion and humanity for our colleagues and customers around the world, and always work for the benefit of India.
Responsibility
We continue to be responsible, sensitive to the countries, communities and environments in which we work, always ensuring that what comes from the people goes back to the people many times over.
Unity
We work cohesively with our colleagues across the group and with our customers and partners around the world, building strong relationships based on tolerance, understanding and mutual cooperation.
Excellence
We constantly strive to achieve the highest possible standards in our day-to-day work and in the quality of the goods and services we provide.
Ram Gulwady
Co-Founder & Managing Partner
Over 20 years of experience in pharmaceutical formulation development, regulatory strategy, and technology transfer. Led 200+ regulatory submissions across US FDA, EMA, and emerging markets.
Smriti Gulwady
Co-Founder & Partner
Extensive expertise in regulatory affairs, quality systems, and analytical development. Strong track record in global pharmaceutical consulting and client relationship management.
Research
Focused R&D approach supporting formulation development and regulatory pathways across global pharmaceutical markets.
Resources
Scientific expertise and technical capabilities enabling efficient development, validation, and regulatory submission.
Global Reach
US FDA
ANDA, NDA, and 505(b)(2)
submissions with strong first-
cycle approval rates.
EMA
Centralised and decentralised
procedures across EU member
states.
WHO PQ
Prequalification support for global
health and access markets.
CDSCO
Indian regulatory filings, import
licenses, and clinical trial
approvals.
Client Feedback
— Senior Director, Regulatory Affairs
Leading Indian Pharmaceutical Company
